Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Organogenesis Holdings' Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $1.1 million for Q3 2020.

• In Q3 2020, Non-Current Deffered Revenue rose 49.18% year-over-year to $1.1 million; the TTM figure through Sep 2020 stood at $1.1 million (up 49.18% YoY), while the FY2019 annual figure was $1.0 million, up 678.46% from the prior year.
• Non-Current Deffered Revenue was $1.1 million for Q3 2020 at Organogenesis Holdings, roughly flat from $1.1 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $10.8 million in Q4 2016 to a low of $74000.0 in Q4 2017.
• Historically, Non-Current Deffered Revenue has averaged $4.8 million across 5 years, with a median of $1.1 million in 2020.
• The sharpest annual moves came in 2017 and 2019: Non-Current Deffered Revenue slumped 99.32% in 2017, then soared 678.46% in 2019.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $10.8 million in 2016, then plunged by 99.32% to $74000.0 in 2017, then surged by 75.68% to $130000.0 in 2018, then jumped by 678.46% to $1.0 million in 2019, then increased by 8.5% to $1.1 million in 2020.
• The last three Non-Current Deffered Revenue figures came in at $1.1 million (Q3 2020), $1.1 million (Q2 2020), and $1.1 million (Q1 2020), per Business Quant data.